Trials / Withdrawn
WithdrawnNCT00184288
Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.
Single Volume 1H MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Norwegian University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to investigate the feasibility of in vivo single volume MR spectroscopy in evaluation of treatment response in patients with brain metastases, using 3T MR instrument. In order to optimize and avoid ineffective treatment of patients with brain metastases, in vivo MR spectroscopy can be an useful tool.
Conditions
Timeline
- Start date
- 2004-11-01
- Primary completion
- 2006-06-01
- Completion
- 2010-12-01
- First posted
- 2005-09-16
- Last updated
- 2011-11-02
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT00184288. Inclusion in this directory is not an endorsement.